A collaboration between PTC Therapeutics and Swiss biotech Roche may speed development of experimental treatments for spinal muscular atrophy

posted on December 1, 2011 - 6:00am
Swiss biotechnology company Roche, and PTC Therapeutics in South Plainfield, N.J., on Nov. 29, 2011, announced a collaboration through which the two companies will work together to advance drug development for spinal muscular atrophy (SMA).

New content is being added every day. Please check back again.